Does VEMURAFENIB Cause Basal cell carcinoma? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Basal cell carcinoma have been filed in association with VEMURAFENIB (ZELBORAF). This represents 0.4% of all adverse event reports for VEMURAFENIB.
35
Reports of Basal cell carcinoma with VEMURAFENIB
0.4%
of all VEMURAFENIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Basal cell carcinoma From VEMURAFENIB?
Of the 35 reports, 1 (2.9%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
Yes, Basal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for VEMURAFENIB.
What Other Side Effects Does VEMURAFENIB Cause?
Rash (1,202)
Arthralgia (783)
Off label use (782)
Fatigue (773)
Diarrhoea (655)
Nausea (601)
Pyrexia (569)
Death (505)
Alopecia (445)
Decreased appetite (383)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which VEMURAFENIB Alternatives Have Lower Basal cell carcinoma Risk?
VEMURAFENIB vs VENETOCLAX
VEMURAFENIB vs VENLAFAXINE
VEMURAFENIB vs VENTAVIS
VEMURAFENIB vs VENTOLIN
VEMURAFENIB vs VENTOLIN HFA